323 related articles for article (PubMed ID: 31002407)
41. The autotaxin-lysophosphatidic acid pathway mediates mesenchymal cell recruitment and fibrotic contraction in lung transplant fibrosis.
Sinclair KA; Yerkovich ST; Hopkins PM; Fieuw AM; Ford P; Powell JE; O'Sullivan B; Chambers DC
J Heart Lung Transplant; 2021 Jan; 40(1):12-23. PubMed ID: 33339555
[TBL] [Abstract][Full Text] [Related]
42. The role of biomechanical anatomical modeling via computed tomography for identification of restrictive allograft syndrome.
Horie M; Saito T; Moseley J; D'Errico L; Salazar P; Nakajima D; Brock K; Yasufuku K; Binnie M; Keshavjee S; Paul N
Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28658530
[TBL] [Abstract][Full Text] [Related]
43. MiR-21 in Lung Transplant Recipients With Chronic Lung Allograft Dysfunction.
Miyahara N; Benazzo A; Oberndorfer F; Iwasaki A; Laszlo V; Döme B; Hoda MA; Jaksch P; Klepetko W; Hoetzenecker K
Transpl Int; 2021; 35():10184. PubMed ID: 35185369
[No Abstract] [Full Text] [Related]
44. Incidence and impact of chronic lung allograft dysfunction after lung transplantation - single-center 14-year experience.
Nykänen A; Raivio P; Peräkylä L; Stark C; Huuskonen A; Lemström K; Halme M; Hämmäinen P
Scand Cardiovasc J; 2020 Jun; 54(3):192-199. PubMed ID: 32148103
[No Abstract] [Full Text] [Related]
45. Characterization of chronic lung allograft dysfunction phenotypes using spectral and intrabreath oscillometry.
Fu A; Vasileva A; Hanafi N; Belousova N; Wu J; Rajyam SS; Ryan CM; Hantos Z; Chow CW
Front Physiol; 2022; 13():980942. PubMed ID: 36277208
[No Abstract] [Full Text] [Related]
46. Bronchoalveolar bile acid and inflammatory markers to identify high-risk lung transplant recipients with reflux and microaspiration.
Zhang CYK; Ahmed M; Huszti E; Levy L; Hunter SE; Boonstra KM; Moshkelgosha S; Sage AT; Azad S; Zamel R; Ghany R; Yeung JC; Crespin OM; Frankel C; Budev M; Shah P; Reynolds JM; Snyder LD; Belperio JA; Singer LG; Weigt SS; Todd JL; Palmer SM; Keshavjee S; Martinu T;
J Heart Lung Transplant; 2020 Sep; 39(9):934-944. PubMed ID: 32487471
[TBL] [Abstract][Full Text] [Related]
47. Radiographic Graft Surveillance in Lung Transplantation: Prognostic Role of Parametric Response Mapping.
Belloli EA; Gu T; Wang Y; Vummidi D; Lyu DM; Combs MP; Chughtai A; Murray S; Galbán CJ; Lama VN
Am J Respir Crit Care Med; 2021 Oct; 204(8):967-976. PubMed ID: 34319850
[No Abstract] [Full Text] [Related]
48. The prognostic importance of CXCR3 chemokine during organizing pneumonia on the risk of chronic lung allograft dysfunction after lung transplantation.
Shino MY; Weigt SS; Li N; Palchevskiy V; Derhovanessian A; Saggar R; Sayah DM; Huynh RH; Gregson AL; Fishbein MC; Ardehali A; Ross DJ; Lynch JP; Elashoff RM; Belperio JA
PLoS One; 2017; 12(7):e0180281. PubMed ID: 28686641
[TBL] [Abstract][Full Text] [Related]
49.
Ciaramelli C; Fumagalli M; Viglio S; Bardoni AM; Piloni D; Meloni F; Iadarola P; Airoldi C
J Proteome Res; 2017 Apr; 16(4):1669-1682. PubMed ID: 28245130
[TBL] [Abstract][Full Text] [Related]
50. Early posttransplant reductions in club cell secretory protein associate with future risk for chronic allograft dysfunction in lung recipients: results from a multicenter study.
Todd JL; Weber JM; Kelly FL; Neely ML; Nagler A; Carmack D; Frankel CW; Brass DM; Belperio JA; Budev MM; Hartwig MG; Martinu T; Reynolds JM; Shah PD; Singer LG; Snyder LD; Weigt SS; Palmer SM
J Heart Lung Transplant; 2023 Jun; 42(6):741-749. PubMed ID: 36941179
[TBL] [Abstract][Full Text] [Related]
51. Bronchiolitis obliterans syndrome-free survival after lung transplantation: An International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysis.
Kulkarni HS; Cherikh WS; Chambers DC; Garcia VC; Hachem RR; Kreisel D; Puri V; Kozower BD; Byers DE; Witt CA; Alexander-Brett J; Aguilar PR; Tague LK; Furuya Y; Patterson GA; Trulock EP; Yusen RD
J Heart Lung Transplant; 2019 Jan; 38(1):5-16. PubMed ID: 30391193
[TBL] [Abstract][Full Text] [Related]
52. Gene Expression Profiling of Bronchoalveolar Lavage Cells Preceding a Clinical Diagnosis of Chronic Lung Allograft Dysfunction.
Weigt SS; Wang X; Palchevskiy V; Gregson AL; Patel N; DerHovanessian A; Shino MY; Sayah DM; Birjandi S; Lynch JP; Saggar R; Ardehali A; Ross DJ; Palmer SM; Elashoff D; Belperio JA
PLoS One; 2017; 12(1):e0169894. PubMed ID: 28103284
[TBL] [Abstract][Full Text] [Related]
53. NKG2C Natural Killer Cells in Bronchoalveolar Lavage Are Associated With Cytomegalovirus Viremia and Poor Outcomes in Lung Allograft Recipients.
Calabrese DR; Chong T; Wang A; Singer JP; Gottschall M; Hays SR; Golden JA; Kukreja J; Lanier LL; Tang Q; Greenland JR
Transplantation; 2019 Mar; 103(3):493-501. PubMed ID: 30211828
[TBL] [Abstract][Full Text] [Related]
54. Chronic Lung Allograft Dysfunction Is Associated with Increased Levels of Cell-Free Mitochondrial DNA in Bronchoalveolar Lavage Fluid of Lung Transplant Recipients.
Schneck E; Askevold I; Rath R; Hecker A; Reichert M; Guth S; Koch C; Sander M; Seeger W; Mayer K; Padberg W; Sommer N; Kuhnert S; Hecker M
J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887906
[TBL] [Abstract][Full Text] [Related]
55. Usefulness of gene expression profiling of bronchoalveolar lavage cells in acute lung allograft rejection.
Weigt SS; Wang X; Palchevskiy V; Li X; Patel N; Ross DJ; Reynolds J; Shah PD; Danziger-Isakov LA; Sweet SC; Singer LG; Budev M; Palmer S; Belperio JA
J Heart Lung Transplant; 2019 Aug; 38(8):845-855. PubMed ID: 31122726
[TBL] [Abstract][Full Text] [Related]
56. The pleural mesothelium and transforming growth factor-β
Sacreas A; von der Thüsen JH; van den Bosch TPP; Weynand B; Verbeken EK; Debbaut C; Van Raemdonck DE; Vos R; Verleden SE
J Heart Lung Transplant; 2019 May; 38(5):570-579. PubMed ID: 30819647
[TBL] [Abstract][Full Text] [Related]
57. Is there any impact of plasma M30 and M65 levels on progression-free survival of patients with advanced gastric cancer?
Bilici A; Ustaalioglu BB; Ercan S; Orcun A; Seker M; Salepci T; Gumus M
Cancer Chemother Pharmacol; 2011 Aug; 68(2):309-16. PubMed ID: 20967544
[TBL] [Abstract][Full Text] [Related]
58. CXCR3 ligands are associated with the continuum of diffuse alveolar damage to chronic lung allograft dysfunction.
Shino MY; Weigt SS; Li N; Palchevskiy V; Derhovanessian A; Saggar R; Sayah DM; Gregson AL; Fishbein MC; Ardehali A; Ross DJ; Lynch JP; Elashoff RM; Belperio JA
Am J Respir Crit Care Med; 2013 Nov; 188(9):1117-25. PubMed ID: 24063316
[TBL] [Abstract][Full Text] [Related]
59. Survival determinants in lung transplant patients with chronic allograft dysfunction.
Verleden GM; Vos R; Verleden SE; De Wever W; De Vleeschauwer SI; Willems-Widyastuti A; Scheers H; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM
Transplantation; 2011 Sep; 92(6):703-8. PubMed ID: 21836537
[TBL] [Abstract][Full Text] [Related]
60. Phenotyping Chronic Lung Allograft Dysfunction Using Body Plethysmography and Computed Tomography.
Suhling H; Dettmer S; Greer M; Fuehner T; Avsar M; Haverich A; Welte T; Gottlieb J
Am J Transplant; 2016 Nov; 16(11):3163-3170. PubMed ID: 27203799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
